Skip to the page

Data / Form D filings / KayoThera, Inc.

KayoThera, Inc.: Form D filings

KayoThera, Inc., a company in Seattle, WA, filed 4 Form D notices with the SEC between 2019 and 2023. The latest, on July 13, 2023, reports $10.5 million sold of a $10.9 million offering to 14 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
2815 Eastlake Avenue East, Suite 300, 155 VILLAGE BLVD., SUITE 130, Seattle, WA, 98102
Phone
(908) 731-6610
Industry
Other
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2019
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1778725

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Jul 13, 2023Amendment$10,856,367$10,456,366$400,00114Mar 11, 2022sec.gov
Mar 31, 2023Amendment$8,000,001$8,000,0015Mar 11, 2022sec.gov
Mar 24, 2022New notice$8,000,001$4,000,001$4,000,0005Mar 11, 2022sec.gov
Jun 5, 2019New notice$750,000$750,0001May 29, 2019sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Thong LeExecutive Officer, Director
Mark EspositoExecutive Officer, Director
Kendall MohlerExecutive Officer, Director
Ian HowesExecutive Officer

Other companies in Washington that filed recently

Every Form D from the week of Jul 10, 2023 · All recent filings in Washington · All recent Other filings

Read from SEC EDGAR. Amount sold is what KayoThera, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.